UK-based Small Pharma Inc will commence trading on the TSX Venture Exchange (via RTO) on May 6, 2021, under the symbol "DMT".
Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands.
They have:
- Stylish products
- World Class Management Team
- A proven and repeatable strategy for success
Experienced and proven luxury cannabis concentrates brand
One of the tops selling vape brands in WA State with a loyal customer base
Largest standalone oil manufacturer in the state of WA
Consistent sales growth over 3 years with a verified marketing blueprint
Offers investors exposure to a premium luxury cannabis brand
Demonstrated to have a winning formula to become the top vape company in WA
Massive growth opportunity available with expansion into OR, NV and CA
UK-based Small Pharma Inc will commence trading on the TSX Venture Exchange (via RTO) on May 6, 2021, under the symbol "DMT".
Mydecine announces a new partnership with LeadGen Labs, aimed at improving its drug synthesis operations.
MindMed commences "Project Angie": psychedelic drug R&D aimed at treating pain, involving psychedelics including LSD.
Psychedelic stocks have become extremely concentrated -- like other sectors. Here's why we see that changing in this sector.
Optimi Health announces its product development agreement with Numinus Wellness is advancing toward a human trial.
Psyched Wellness has contracted with a Lithuanian company to obtain 200 kgs of Amanita muscaria mushroom caps.